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Abstract
Background: To improve care for children in district hospitals in Kenya, a multifaceted approach employing guidelines,
training, supervision, feedback, and facilitation was developed, for brevity called the Emergency Triage and Treatment Plus
(ETAT+) strategy. We assessed the cost effectiveness of the ETAT+ strategy, in Kenyan hospitals. Further, we estimate the
costs of scaling up the intervention to Kenya nationally and potential cost effectiveness at scale.
Methods and Findings: Our cost-effectiveness analysis from the provider’s perspective used data from a previously
reported cluster randomized trial comparing the full ETAT+ strategy (n=4 hospitals) with a partial intervention (n=4
hospitals). Effectiveness was measured using 14 process measures that capture improvements in quality of care; their
average was used as a summary measure of quality. Economic costs of the development and implementation of the
intervention were determined (2009 US$). Incremental cost-effectiveness ratios were defined as the incremental cost per
percentage improvement in (average) quality of care. Probabilistic sensitivity analysis was used to assess uncertainty. The
cost per child admission was US$50.74 (95% CI 49.26–67.06) in intervention hospitals compared to US$31.1 (95% CI 30.67–
47.18) in control hospitals. Each percentage improvement in average quality of care cost an additional US$0.79 (95% CI
0.19–2.31) per admitted child. The estimated annual cost of nationally scaling up the full intervention was US$3.6 million,
approximately 0.6% of the annual child health budget in Kenya. A ‘‘what-if’’ analysis assuming conservative reductions in
mortality suggests the incremental cost per disability adjusted life year (DALY) averted by scaling up would vary between
US$39.8 and US$398.3.
Conclusion: Improving quality of care at scale nationally with the full ETAT+ strategy may be affordable for low income
countries such as Kenya. Resultant plausible reductions in hospital mortality suggest the intervention could be cost-
effective when compared to incremental cost-effectiveness ratios of other priority child health interventions.
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Introduction
An estimated 7.6 million children die globally every year before
the age of five [1]. 99% of these deaths occur in developing
countries; 50% in sub-Saharan Africa [2]. Most of these deaths are
due to a few treatable and preventable diseases, for which effective
interventions are already available [3,4]. Delivering these inter-
ventions is essential to achieving the 4th Millennium Development
Goal (MDG), which aims to reduce the under-five mortality rate
by two-thirds by 2015. In Kenya, the under-five mortality rate has
to be reduced by 50% from its 2008 level to meet the MDG target.
Improving case management of serious illness might help achieve
this goal [5,6], and we have recently described one possible
approach to this in Kenyan district hospitals [7]. That approach
included the development and implementation of evidence-based
clinical practice guidelines (CPGs) linked to health worker
training, follow-up supervision, performance feedback, and
facilitation (for brevity referred to as the ETAT+ strategy) [8,9].
However, while the strategy was effective, would scaling up the
approach be a good use of limited resources? Addressing this
question demands a rigorous evaluation of costs and consequences
with such data used to estimate the costs and effects of scaling up
the intervention to reach the population in need. This paper
presents a cost-effectiveness analysis performed alongside the
previously reported cluster randomized trial of the effects of the
PLoS Medicine | www.plosmedicine.org 1 June 2012 | Volume 9 | Issue 6 | e1001238ETAT+ strategy. We also present an assessment of the costs of
scaling up the intervention to the national level and speculate on,
using a simple model that assumes the strategy reduces inpatient
mortality, the possible costs per disability adjusted life year
(DALY) averted.
Methods
Study Design
This was a cost-effectiveness analysis alongside a cluster
randomized controlled trial (cRCT). The time horizon selected
was 18 mo (September 2006–April 2008), which was the period
during which the intervention was implemented and evaluated.
Costing took a provider’s perspective. While this is often
considered narrow [10,11], for the purpose of this analysis, we
considered it sufficient as it encompasses the relevant range of costs
and effects of interest to policy makers responsible for budgeting
and planning for scale-up in Kenya. To account for differential
timing and time preference, we discounted costs and outcomes
using a 3% annual discount rate [12]. Costs were adjusted for
inflation using gross domestic product (GDP) deflators for Kenya
[13] and are valued and presented in 2009 US$. Effects are
measured in terms of process indicators of quality of care that
include important measures of child assessment, diagnosis,
classification, and treatment on admission. Probabilistic sensitivity
analysis using Monte Carlo simulation was used to assess the
impact of uncertainty around hotel costs, development costs,
medicine costs, staff salaries, and effectiveness estimates.
Data Collection and Sample Sizes
In this cRCT (described in full elsewhere [7]), eight rural district
hospitals in four provinces in Kenya were randomized into four
full and four partial intervention hospitals, hereafter termed
intervention and control hospitals [7]. Resource use data were
collected via clinical record reviews conducted at baseline and at
6-monthly intervals over an 18-mo period (four surveys in total).
During each survey, these reviews were conducted on 400
randomly selected pediatric admissions. Admissions were included
if children, aged between 2 and 59 mo, were admitted for acute
illnesses during the preceding 6-mo time period. The total sample
included 6,199 and 5,115 record reviews of pediatric admissions
for intervention and control hospitals, respectively. The clinical
performance indicators used as the measure of effectiveness in this
analysis were extracted from 1,158 and 1,157 records at 18 mo
post implementation in the intervention and control hospitals,
respectively.
The Intervention
The intervention was a package of care intervention that was
delivered in the form of evidence-based CPG dissemination [8],
health worker training, job aids, follow-up supervision, and local
(health facility) facilitation by a nurse or diploma level clinician
[7,9]. The role of the local facilitator was to offer local oversight
and on-site problem solving to support facilities implementing the
intervention. The training course was developed from the existing
World Health Organization (WHO) Emergency Triage, Assess-
ment and Treatment (ETAT) course with the addition of new
materials on newborn resuscitation and case management of
common causes of serious illness in the newborn or child and with
the CPGs spanned: emergency pediatric care, malaria, pneumo-
nia, asthma, diarrhea and dehydration, meningitis, malnutrition,
and neonatal care [8]. This new training was therefore given the
name ‘‘Emergency Triage Assessment and Treatment Plus
Admission Care (ETAT+).’’
In intervention hospitals, the intervention was delivered over
18 mo as a combination of ETAT+ training for health care
workers conducted over 5.5 d, dissemination of CPG booklets, job
aids, and pediatric admission record (PAR) forms [7]. The PAR is
a structured form used by clinicians to document key symptoms
and signs of a sick child’s clinical information on admission [14].
This was followed by 2–3-monthly supervisory visits that
sometimes included short, ad hoc follow-up training and
appointment of a local facilitator in each facility linked to hospital
supervisors by regular phone calls from the study team [9,15].
Results and feedback reports of the surveys conducted in the
facilities were disseminated in face-to-face meetings in intervention
hospitals.
In the control hospitals, a partial version of the intervention was
delivered in the form of CPG booklet distribution, a 1.5-d seminar,
and provision of written survey feedback based on written reports
only. Control hospitals did not receive any follow-up supervisory
support or local facilitation.
Evaluating Effectiveness
We used process indicators of quality of care to estimate the
effectiveness of the intervention. In total 14 pre-specified indicators
that span three broad areas were considered as primary outcomes
[7]: assessment of a severely ill child, therapeutic care, and
supportive care on admission. These indicators cover the diseases
(malaria, pneumonia, and diarrhea/dehydration) that result in
60% of inpatient deaths in children under five in Kenya.
Effectiveness was then estimated as the between-group (interven-
tion and control) difference using logistic or linear regression
analyses for each of the 14 process measures while adjusting for
hospital-level covariates (all-cause pediatric mortality, malaria
transmission, and hospital size). This procedure is described in
detail elsewhere [7]. Further details of the effectiveness analysis are
also provided in Figure S1.
Evaluating Costs
Costs were categorized as intervention development, interven-
tion implementation, and inpatient pediatric treatment costs. The
latter were included in order to capture any change in resource use
associated with the implementation of best practice pediatric care.
Costs were summed across all categories to obtain the total cost
per hospital and per hospital admission in intervention and control
hospitals. Each cost category is further described in the following
sections. Costs were collected using clinical and accounting record
reviews and interviews with those involved in developing and
implementing the intervention.
Guideline Development Costs
Development costs included the staff costs incurred in the
development of ETAT+ guidelines and training, the costs of
course training materials, and costs of organizing and running
meetings and workshops. Staff costs were calculated by interview-
ing key staff involved in guideline development in order to estimate
the amount of time spent on these activities. The opportunity cost
of this time was then assumed to be equivalent to the associated
cost of employment. The costs of course training materials were
assumed to be equivalent to the market prices of these items.
Development costs were annualized over 4 y, which was assumed
to be the useful life of the clinical guidelines.
Guideline Implementation Costs
Implementation costs included the costs of initial ETAT+
training of health workers, follow-up training, supervisory visits
Cost Effectiveness of Hospital Quality Improvement
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costs. The opportunity costs of resources used in these activities,
e.g., staff time used in attending trainings, were evaluated by
estimating the number of days spent at each training workshop
and calculating the costs on the basis of the equivalent cost of
employment. The costs of the initial training were considered to be
capital costs as the effects of the training were expected to be
realized over a period of more than 1 y. These costs were
annualized over a useful life of 2.5 y, which was the length of time
over which the practice change effects were seen to be sustained
[7]. Follow-up activities and supervision were considered to be
recurrent costs.
Treatment Costs
Treatment costs were computed as the sum of ‘‘hotel,’’
medicine, and laboratory costs per admission. Resource use data
for patient length of stay in hospital, medicines, and laboratory
tests were collected from patient clinical records. Estimates of the
utilization of these resources were then multiplied against the unit
cost of each item. Per diem ‘‘hotel’’ unit costs were derived from
the WHO, ‘‘Choosing Interventions that are Cost Effective’’
(WHO-CHOICE) estimates and recent work on the economic
costs of inpatient care in Kenya [16,17]. Medicine unit costs were
derived from 2009 market prices while unit costs of diagnostic tests
were based on non-profit cost recovery prices from a Kenyan
district hospital [16]. Given the skewed nature of cost data,
treatment costs are presented as both means (with confidence
intervals) and medians (with interquartile ranges).
Evaluating Cost Effectiveness
The cost-effectiveness analysis compared the implementation of
the ETAT+ strategy as delivered in the intervention hospitals with
the partial intervention as delivered in the control hospitals. The
partial intervention was chosen as a comparator because it mirrors
practice that would be considered a basic, standard approach to
dissemination of guidelines that does not typically include active
follow-up or supervision and for ethical reasons (withholding new
national guidelines was deemed unreasonable). While ‘‘no
intervention’’ is an alternative counterfactual, this assumes,
somewhat unrealistically to us, that no national or international
body will produce guidelines or disseminate them or make
attempts to improve poor hospital services.
The summary measure of effect was the mean of the adjusted
differences between control and intervention hospitals at 18 mo.
This was calculated as the mean percentage improvement in the
14 process of care indicators in intervention compared to control
hospitals (Equation 1), with 95% CIs obtained by bootstrapping
with 2000 iterations.
Measure of effectiveness: Q~
X14
i~1 Ei=n ð1Þ
Where: Q, mean percentage improvement in process of care; Ei,
adjusted difference of each process of care between control and
intervention hospitals at 18 mo; n, number of processes of care.
Assessing Cost Effectiveness
The incremental cost-effectiveness ratio (ICER) was defined as
the incremental cost per percentage gain in mean quality based on
the 14 indicators. This is the ratio of the difference in the total
admission cost per child between intervention and control
hospitals, and the difference in mean quality improvement
(Equation 2).
ICER~(Ci{Cc)=Ei{Ec) ð2Þ
Where: Ci, child admission costs in intervention hospitals; Cc, child
admission costs in control hospitals; Ei, percentage improvement
in process measures of quality in intervention hospital; Ec,
percentage improvement in process measures of quality in control
hospitals.
The cRCT was not designed to examine effects on health
outcomes, therefore we explored the potential incremental cost per
DALY averted on the basis of conservative assumptions of the
effect of improving quality of care on inpatient childhood
mortality. We assumed relative reductions in the mortality rate
of between 1% and 10%, equivalent to absolute reductions of
between 0.07% and 0.7% with median inpatient mortality,
derived from the eight hospitals, equal to 7%. The proportion of
lives saved from the respective diseases (malaria, pneumonia, and
diarrhea) were assumed to be equivalent to the proportions of the
contribution of each of these diseases to under-five childhood
deaths in Kenya [18]. In this ‘‘what-if’’ analysis, the intervention
was compared to common practice where guidelines are
developed and disseminated with no accompanying training
and/or follow-up supervision. DALYs were calculated using
standard methods [19]. DALYs are generic measures of health
outcomes derived by adding the years of life lost due to disease
(YLL) and the years of life lived with disability (YLD) [19–21].
DALYs were calculated using a discount rate of 3%, age weighting
and disability weights for malaria episode (0.19), lower respiratory
infection episode (0.28), and diarrheal diseases (0.11) [22].
Separate DALY calculations for each of these diseases where
made and summed up to yield total DALYs averted by the
intervention.
Total Costs of Scale-up
Kenya has 121 hospital facilities with estimated median annual
pediatric admissions of 2,000 per facility across this group,
representing a total for pediatric admissions of 242,000 per
annum (there are a larger number of smaller hospitals not
considered in this analysis). We estimated the cost of scaling up this
intervention with a number of assumptions: (1) Development costs
do not vary with scale-up; given that they are only incurred once,
they are not a function of the scale of the intervention; (2) That
training, supervision, and follow-up costs (implementation) vary as
a function of the number of hospitals; (3) That treatment costs vary
as a function of the number of pediatric admissions; (4)That the
intervention would reach all 121 hospitals when at scale. It is
however difficult to estimate potential economies of scale and
scope, for example for supervision, that might lessen costs or
specific, higher, travel costs for hard to reach areas during scale
up. Given the skewness of treatment costs, their scale-up
component costs were calculated on the log-scale and then back
transformed to the original scale.
Sensitivity Analysis
Uncertainty was addressed by specifying distributions around
cost and effectiveness parameters and conducting probabilistic
sensitivity analysis using Crystal Ball software (Decisioneering).
Triangular distributions with plausible ranges were fitted around
the effectiveness estimate, development costs, salaries, medicines,
and ‘‘hotel’’ components of costs (Table 1). Intervention effective-
ness was varied to reflect the range of process of care
improvements between intervention and control hospitals across
the 14 indicators; from 3.54%, to 52.10%, the smallest and
Cost Effectiveness of Hospital Quality Improvement
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hospitals’ indicators. Development costs were varied to reflect a
scenario where a ‘‘ready made’’ intervention was adopted hence
having zero intervention costs, and a scenario where the full
development costs were incurred. The ‘‘hotel’’ unit cost estimate
used in the base case, which was also used to compute the lower
range in the sensitivity analysis, was the WHO-CHOICE estimate
for district hospitals in Kenya, inflated to 2009 (US$6.96 per day)
[23], while the upper range was computed from an estimate from
a Kenyan study inflated to 2009 (US$15.05 per day) [24]. The
lower range of salary costs was derived by assuming the
intervention implementers were compensated at government of
Kenya salary scales while the upper limit, which was also the
estimate used in base case, assumed that intervention implemen-
ters were compensated at the salary scales of the research
organization that implemented the intervention. The range of
medicine costs was derived from variations in market prices in the
2010 Kenya drug prices catalogue. Confidence intervals around
the mean ICER were derived from 1,000 Monte Carlo
simulations.
Results
Changes in Process of Care Measures
The mean of the adjusted differences of the 14 process measures
between control and intervention hospitals was 25.01% (95% CI
17.87%–32.18%). The findings of performance changes across all
process measures in both control and intervention hospitals are
presented in Table 2.
Intervention Costs
Total intervention costs and admission costs per child in
intervention and control hospitals are presented in Table 3. An
average of 32 health workers underwent the initial ETAT+
training at a cost of US$8,069.32 per intervention hospital or
US$252.16 per trainee. Follow-up training, supervision, and local
facilitator costs were 19.89% of total intervention costs in
intervention hospitals. The annual costs of a local facilitator per
facility were US$5,697.87, 5.62% of total intervention costs in
intervention hospitals.
Treatment Costs
An ordinary linear (OLS) regression of (log transformed)
treatment costs revealed that costs did not significantly vary with
child diagnosis, hospital, and time (i.e., across the four surveys)
(unpublished data). We therefore pooled treatment costs across
surveys and diagnoses within each study arm to increase sample
sizes. The mean and median treatment costs were US$28.15 (95%
CI 27.61–28.70) and US$22.47 (interquartile range [IQR] 14.33–
32.78), respectively, in intervention hospitals and US$25.10 (95%
CI 24.56–25.65) and US$19.25 (IQR 13.01–29.04) in control
hospitals. ‘‘Hotel’’ costs were the key driver of treatment costs and
contributed between 73.18% and 79.98% of treatment costs.
Treatment costs disaggregated by category are presented in Table
S1, while treatment costs per admission episode are presented in
Table S2.
Incremental Costs, Effects, and Cost-Effectiveness
Analysis
The incremental cost per admission in intervention hospitals
compared to control hospitals was US$19.68 (95% CI 5.31–
31.92). The incremental cost per percentage improvement in
quality of care was US$0.79 (95% CI 0.19–2.31) per child
admission. These results are presented in Table 4.
Estimated Costs of Scale-up and Budget Impact
For an estimated coverage of 121 district hospitals and 242,000
annual under-five admissions, the estimated costs of scale-up were
found to be US$3,559,328.78. This amount is estimated to be
equivalent to 0.60% of the estimated 2010 annual budget for
formal provision of care to children under five in Kenya (Table 5).
Incremental Cost per DALY Estimates Given Probable
Reductions in Mortality
The mean baseline inpatient child mortality rate in the eight
hospitals was 7% [7]. Assuming the intervention produces a 1%–
10% relative reduction in this mortality rate (absolute reductions
between 0.07% and 0.7%), the incremental cost per DALY
averted would range between US$398.3 and US$39.8, respective-
ly. Figure 1 explores the relationship between reduction in
mortality and intervention cost effectiveness at different baseline
mortality rates while Table 6 compares the range of potential
ICERs with those from other key child health interventions that
are considered cost effective.
Sensitivity Analysis
The incremental cost-effectiveness ratios were robust to changes
in most of the variables included in the sensitivity analysis. Four
factors (intervention effectiveness, hotel costs, medicine costs, and
staff salaries) contributed 99% of the total variance in the ICER
(Figure 2). The major contributors to this variance were
Table 1. Parameter ranges and distributions.
Parameter (Costs per Child Admission) Base Case (US$) Range (US$) Distribution
Full intervention development costs 8.11 0–8.11 Triangular
Partial intervention development costs 4.95 0–4.95 Triangular
Full intervention salary costs 12.46 11.42–12.46 Triangular
Full intervention hotel costs 20.68 20.68–39.93 Triangular
Full intervention medicine costs 2.30 0.66–8.06 Triangular
Partial Intervention salary costs 3.65 1.67–3.65 Triangular
Partial intervention hotel costs 20.15 20.15–38.89 Triangular
Partial intervention medicine costs 1.74 0.50–6.09 Triangular
Intervention Effectiveness 25.01 3.54–52.10 Triangular
doi:10.1371/journal.pmed.1001238.t001
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medicine costs contributed to 4% of ICER variance each, while
development costs contributed 1% of the variation. The higher the
intervention effectiveness, the lower the ICER (increased inter-
vention cost effectiveness), while the higher the costs (hotel, salary,
medicine, development costs) the higher the ICER (reduced
intervention cost effectiveness).
Discussion
This analysis compares the costs and effects of a guideline-based
intervention aimed at improving the quality of care of children
admitted to district hospitals in Kenya. In analyzing the costs, we
included the costs of developing clinical guidelines that are often
left out in such analyses [25]. Our analysis revealed that these costs
formed 16% of the overall intervention costs, suggesting that this
component is an important cost driver that should not be ignored.
The development costs are however minimal at scale-up, given
that they are incurred once and do not vary with the scale of the
intervention. The average training cost per health worker was
US$252.16, which is significantly lower than training costs for
similar interventions such as Integrated Management of Child-
hood Illness (IMCI) where the reported median cost was US$633
[26]. One of the unique components of this intervention was the
appointment of a local facilitator in intervention hospitals. The
annual cost of this facilitator per facility was US$5,698. The local
facilitator worked at the facility for the entire intervention period.
This provided continuity and helped to keep the ‘‘quality agenda’’
on the table [27].
There are many challenges in undertaking cost-effectiveness
analyses of interventions targeting hospitals and multiple diseases.
Basic challenges include the lack of high quality data on hotel
costs. These represent between 73% and 80% of total treatment
costs for children admitted with common diseases even though
inpatient stays are typically 3 d or less. We used the WHO-
CHOICE hotel cost estimates applicable to district hospitals in
Kenya. In effect, the use of these data amounts to an assumption
that there are no major differences in the intensity of staffing per
patient. While this assumption was justified as we did not expect
that our intervention would require different levels of health
Table 3. Summary of intervention costs.
Cost Items Intervention Hospitals Control Hospitals
As Percent of Total
Intervention Costs
Cost per
Hospital US$
Cost per
Patient US$
a
As Percent of Total
Intervention Costs
Cost per
Hospital US$
Cost per
Patient US$
Guideline development costs
Development costs 16,227.46 8.11 15.98 9,898.29 4.95 15.93
Training material costs 692.92 0.35 0.69 0.00 0.00 0.00
Total start-up costs 16,920.39 8.46 16.67 9,898.29 4.95 15.93
Implementation costs
Initial training 8,069.32 4.03 7.94 2,017.33 1.01 3.25
Follow-up activities
Follow-up trainings 4,348.05 2.17 4.28 0.00 0.00 0.00
Local facilitator costs 5,697.87 2.85 5.62 0.00 0.00 0.00
Supervision costs 10,135.50 5.07 9.99 0.00 0.00 0.00
Total follow-up costs 20,181.42 10.09 19.89 0.00 0.00 0.00
Total implementation costs 28,250.73 14.13 27.85 2,017.33 1.01 3.25
Start-up and implementation 45,171.11 22.59 44.52 11,915.62 5.96 19.19
Treatment costs
Hotel costs 45,080 22.54 44.42 41,800 20.90 67.28
Drug costs 5,080 2.51 4.95 3,600 1.80 5.80
Lab costs 11,260 5.63 11.10 6,660 3.33 10.72
Total treatment cost 56,304.79 28.15 55.48 50,202.30 25.10 80.81
Total costs 101,475.90 50.74 — 62,117.92 31.06 —
aObtained by dividing the total cost per hospital by the estimated number of annual admissions for children under five per hospital (2,000).
doi:10.1371/journal.pmed.1001238.t003
Table 4. Cost-effectiveness analysis.
Strategy
Mean Admission Costs per
Child US$ (95% CI)
Incremental Cost US$
(95% CI)
Incremental Effects (Percent Change in
Quality of Care) (95% CI) ICER (95% CI)
Partial intervention 31.06 (30.67–47.18) — — —
Full Intervention 50.74 (49.26–67.06) 19.68 (5.31–31.92) 25.01% (17.87–32.18) 0.79 (0.19–2.31)
doi:10.1371/journal.pmed.1001238.t004
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that poor primary data is a potential shortcoming and suggest that
addressing this information gap is a priority.
Specifying summary measures that capture intervention effects
is also a challenge [28]. We used a mean percentage improvement
in quality assessed across 14 indicators for the three major causes
of admission and inpatient death in children [7]. By this measure,
intervention hospitals outperformed control hospitals by 25%.
However, such a measure gives equal weight to each indicator,
with which some might disagree. This assumption is, however,
consistent with findings from an international Delphi study
conducted with pediatric experts where the respondents rated
these 14 process of care indicators as having similar priority for
improvement [29]. It can be argued however that certain process
measures, for example those targeting appropriate dosing of
medicines, are more important than others, such as processes that
target patient assessment. Despite the lack of an agreed weighting
for these processes, we explored a weighting procedure (unpub-
lished data) that gives higher weight to treatment processes (weight
3), followed by diagnosis processes (weight 2), and lastly assessment
processes (weight 1). The resultant effect size (24.0%) was not
significantly different from the unweighted estimate (25.01%) and
fell within the range used in the sensitivity analysis. The
effectiveness measure also fails to capture potentially important
Table 5. Total costs of scale-up.
Description Full Intervention US$ Partial Intervention US$
n district hospitals 121 121
Estimated annual pediatric admission to district hospitals in Kenya 242,000 242,000
Costs of national scale-up 3559328.78 271386.32
Budget for provision of under-five child health services in Kenya in 2010
a 572,000,000 572,000,000
Impact of scaling up ETAT+ on the annual child health budget 0.60% 0.06%
aEstimates of annual budget (2010) for provision of care to children under five derived from the Kenya national health sector strategic plan 2 (NHSSP II).
doi:10.1371/journal.pmed.1001238.t005
Figure 1. Relationship between reductions in inpatient mortality and the incremental cost per DALY averted.
doi:10.1371/journal.pmed.1001238.g001
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improved organization of care, better local resource mobilization
[7], more rational use of antibiotics [30], and positive effects on
staff morale [15]. Conversely the measure does not capture
potential declines in quality in other areas that are not the focus of
intervention. Methodological research is thus needed to optimize
effect measures for complex interventions targeting improvements
in hospital care for multiple diseases.
While acknowledging these limitations our findings suggest an
additional cost of US$0.79 per child admitted to achieve a one
Table 6. Cost per DALY averted estimates of comparable child health interventions.
Child Health Intervention Incremental Cost per DALY Averted US$
a
Expanded immunization programme [39] 13.0–26.1
Hemophilus Influenzae vaccine (Hib) [46] 32.4–78.6
Provision of insecticide treated nets (ITNs) [38] 34.6–154.8
Improving inpatient care of very sick children (assuming between 10% and 1% reduction in baseline inpatient
mortality rate)
39.8–398.3
Integrated Management of Childhood Illnesses (IMCI) [47] 47.1–157.1
Pneumococcal conjugate vaccine [48] 71.1–230.7
Oral rehydration therapy (ORT) [39] 172.2–3352.0
Measles immunization [39] 335.2–5954.1
Breast feeding promotion programmes [39] 687.4–2609.9
aICER values adjusted to 2009 values using GDP deflators.
doi:10.1371/journal.pmed.1001238.t006
Figure 2. Parameter contribution to ICER variance.
doi:10.1371/journal.pmed.1001238.g002
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The probabilistic sensitivity analysis reveals that hotel costs and
intervention effectiveness contributed to more than 80% of the
variation in this ICER. This finding has two implications: (1) The
sensitivity analysis underlines the effects of poor data on hotel costs
and methodological deficiencies in computing a summary measure
of quality improvement; (2) Hotel costs (being key drivers of
treatment costs) and intervention effectiveness have a significant
impact on the cost effectiveness of this quality of care intervention.
Translating improvements in process measures into improved
health status outcomes is problematic and the cluster randomized
trial was not designed to measure effects on inpatient child
mortality [31]. However, to provide some means to consider the
potential value of the intervention in terms of incremental cost per
DALY averted and life years gained, we conducted a simple
‘‘what-if’’ analysis. We considered a reasonably conservative range
of relative reductions in baseline mortality of between 1% and
10%, absolute reductions of mortality of 0.7% to 0.07% from a
baseline of 7%. This range of mortality reductions is considered
conservative when compared to findings suggesting improved case
management for common childhood diseases in primary care may
result in mortality reduction of 13% in Tanzania [32]. Also,
evaluations of quality improvement and safety programmes in
developed countries have reported mortality reductions of between
5% and 51% [33–37]. The implication is that the cost effectiveness
of the interventions is likely to be more favorable than we have
suggested. The findings suggest that the incremental cost per
DALY averted from scaling up the intervention would vary from
US$39.8 to US$398.3. These ICERs compare favorably with
other key public health interventions to reduce child mortality
considered to be cost effective such as provision of insecticide
treated bed nets (US$34.60–US$154.8 per DALY averted) [38] or
oral rehydration therapy (ORT) (US$172.2–US$3352.0 per
DALY averted) [39]. The intervention is likely most cost effective
when hospital mortality is high (Figure 1) and baseline quality of
care poor. Such analyses raise the question of whether quality
improvement should be targeted at high mortality hospitals. While
such simple modeling approaches suggest improving the quality of
rural hospital care may be highly cost effective, demonstrating
such small reductions in mortality in a randomized controlled trial
would be extremely difficult. For example, demonstrating an
absolute, inpatient mortality reduction of 0.5% from a baseline of
7% in a typical cluster randomized trial, using conventional values
for statistical significance and power, would likely require all 121
Kenyan hospitals to be enrolled, randomized, and evaluated over
1 y [40]. The costs of such a trial would be prohibitively high and
would amount to scaling up anyway.
Often the feasibility of scaling up is determined by likely costs.
For the multifaceted intervention employed these were estimated
to be US$3,559,328 if conducted by non-government personnel
and 27% less if by government personnel. This amount can be
compared with average annual projected expenditures by the
Kenyan government on all care for children under five of US$572
million [41] and on other specific health projects such as the
distribution of insecticide treated nets (US$8 million) and
prevention of mother to child transmission of HIV (US$6 million)
[42]. While the costs of scale-up might be small (approximately
0.6% of the child health budget), scaling up the ETAT+
intervention nationally would either require the child health
budget to be increased or that allocation to other areas be reduced
by an equivalent amount.
Cost-effectiveness and affordability data are, however, not the
only factors that should inform such allocative decisions. Other
important considerations may include, equity, likely collateral
benefits or adverse effects, and, of course, context and the politics of
the day. Unfortunately methods to support and make transparent
such complex prioritization decisions remain poorly developed.
Advantages of scaling up such an integrated package of interven-
tions encompassed in the ETAT+ strategy include potentially
important externalities related to more general health system
strengthening and introduction of a culture of improvement [7,27].
For those in other settings reviewing these results, it should be clear
that the greatest apparent cost effectiveness is likely to occur in
settings providing, reliably, a minimum set of basic resources but
wherequalityofcare,intermsofprocess,ispoorandmortalityhigh.
Findings from this work are therefore likely to be generalizable to
low-income countries with similar public hospital characteristics,
child burden of disease, and comparable quality of delivery of
pediatric care as found in hospitals at baseline in Kenya.
Our work adds to a very small body of literature on economic
evaluation of quality of care interventions [43]. The few that are
available fromlow-income settings,including evaluationsofIntegrated
Management of Childhood Illness (IMCI), adopted a similar
approach [32,44,45]. A major limitation of these approaches is that
they fail to fully elucidate the value of the intervention to the patients,
health workers, and organizations, and by extension to decision
makers. Further, because effect measures are unique to the
interventions it is not possible to compare results directly with other
cost-effectiveness or cost-utility studies. To provide a more explicit
framework for comparison requires modeling the link between process
measures of improved quality and health outcomes, which would be
complex and likely based largely on expert opinion. As an alternative
we used an approach that explored potentially plausible overall effects
on hospital mortality. This can clearly be challenged but is mainly
used for illustration. In the absence of data on mortality effects perhaps
a method of valuing quality improvement interventions that
encompasses more than health outcomes might be more appropriate
and could reflect utility by, for example, eliciting society’s preferences.
Conclusion
This analysis has shown that the improvement in quality of care
attributed to the ETAT+ strategy (7) is associated with additional
costs that are affordable to low-income countries like Kenya. The
interventionmayberelativelycost effective comparedwith standard
care if the improvements observed are associated with reasonably
conservative reductions in inpatient child mortality. The absolute
costs for scaling up are comparable to or lower than costs of other,
major child health interventions. As increasing focus is being given
tostrengthening health systems therewould therefore appeartobe a
reasonably strong case for scaling up this intervention that improves
service provision in rural hospitals for the major causes of child
mortality in Kenya. This work also highlights the need for
methodological developments in the economic analysis of complex,
system-level interventions. These results are likely to be most
usefully generalized to low-income countries beyond Kenya with
similar facilities, burden of child mortality, and comparable or
worse quality of pediatric care in hospitals.
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Background. According to latest global estimates from
UNICEF, 7.6 million children currently die every year before
they reach five years of age. Half of these deaths occur in
children in sub-Saharan Africa and tragically, most of these
deaths are due to a few treatable and preventable diseases,
such as pneumonia, malaria, and diarrhea, for which effective
interventions are already available. In order to meet the
target of the 4th Millennium Development Goal—which
aims to reduce the under-five child mortality rate by two-
thirds from 1990 levels by 2015—delivering these interven-
tions is essential.
In Kenya, the under-five child mortality rate must be reduced
by half from its 2008 level in order to meet the Millennium
Development Goal (MDG) target and so improving the
management of serious child illness might help achieve this
goal. A study published last year in PLoS Medicine described
such an approach and included the development and
implementation of evidence-based clinical practice guide-
lines linked to health worker training, follow-up supervision,
performance feedback, and facilitation in eight district
hospitals in Kenya.
Why Was This Study Done? In the study mentioned
above, the researchers compared the implementation of
various processes of care in intervention and control
hospitals at baseline and 18 months later and found that
performance improved more in the intervention hospitals
than in the control hospitals. However, while this strategy
was effective at improving the quality of health care, it is
unclear whether scaling up the approach would be a good
use of limited resources. So in this study, the same
researchers performed a cost-effectiveness analysis (which
they conducted alongside the original trial) of their quality
improvement intervention and estimated the costs and
effects of scaling up this approach to cover the entire
population of Kenya.
What Did the Researchers Do and Find? In order to
perform the cost part of the analysis, the researchers
collected the relevant information on costs by using clinical
and accounting record reviews and interviews with those
involved in developing and implementing the intervention.
The researchers evaluated the effectiveness part of the
analysis by comparing the implementation of their improved
quality of care strategy as delivered in the intervention
hospitals with the partial intervention as delivered in the
control hospitals by calculating the mean percentage
improvement in the 14 process of care indicators at 18
months. Finally, the researchers calculated the costs of
scaling up the intervention by applying their results to the
whole of Kenya—121 hospital facilities with an estimated
annual child admission rate of 2,000 per facility.
The researchers found that the quality of care (as measured
by the process of care indicators) was 25% higher in
intervention hospitals than in control hospitals, while the
cost per child admission was US$50.74 in intervention
hospitals compared to US$31.1 in control hospitals. The
researchers calculated that each percentage improvement in
the average quality of care was achieved at an additional
cost of US$0.79 per admitted child. Extrapolating these
results to all of Kenya, the estimated annual cost of scaling
up the intervention nationally was US$3.6 million, about
0.6% of the annual child health budget in Kenya.
What Do These Findings Mean? The findings of this cost-
effectiveness analysis suggests that a comprehensive quality
improvement intervention is effective at improving stan-
dards of care but at an additional cost, which may be
relatively cost effective compared with basic care if the
improvements observed are associated with decreases in
child inpatient mortality. The absolute costs for scaling up
are comparable to, or even lower than, costs of other, major
child health interventions. As the international community is
giving an increasing focus to strengthening health systems,
these findings provide a strong case for scaling up this
intervention, which improves quality of care and service
provision for the major causes of child mortality, in rural
hospitals throughout Kenya and other district hospitals in
sub-Saharan Africa.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001238.
N Theresearchers’ original article appeared inPLoS Medicine in
2011: Ayieko P,NtoburiS,WagaiJ,OpondoC,OpiyoN,etal.
(2011) A Multifaceted Intervention to Implement Guidelines
and Improve Admission Paediatric Care in Kenyan District
Hospitals: A Cluster Randomised Trial. PLoS Med 8(4):
e1001018. doi:10.1371/journal.pmed.1001018
N The IDOC Africa provides further information on the ETAT+
strategy
N The World Health Organization (WHO) provides informa-
tion on MDG 4, including strategies to reduce global
child mortality) and the WHO pocket-book ‘‘Hospital care
for children’’ includes guidelines for the management of
common but serious childhood illnesses in resource-
limited settings
N UNICEF www.unicef.org also publishes information on
global child mortality rates and the ountdown to 2015
website tracks coverage levels for health interventions
proven to reduce child mortality
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